Adela
Latest round
- Series A
Last raised
- Jun 2021
Total raised
- $60M
Investors
- 5
About Adela
, provides a diagnosis of cancer. The company was co-founded by Daniel Carvalho and Scott Bratman. The company develops a methylation enrichment technology that detects signals of early disease with high sensitivity through efficient mining of the entire methylome. The company's technology is primarily focused on the detection of diseases like cancer and other high morbidity and mortality conditions. The company's revenue is generated by the sales of its methylation enrichment technology to its target market that includes various medical institutions. The company plans to develop its technology to use across the entire cancer continuum for detection, diagnosis, and management of a disease. The company also plans to advance its technology towards commercialization.
Who invested in Adela
5 investors across 1 round
See all investors in Adela
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 23, 2021
Amount
$60M
Investors
Questions about Adela
Who invested in Adela?
Adela has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Adela raised?
Adela has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Adela last raise money?
Adela's most recent round on record is a Series A, in Jun 2021.
What does Adela do?
, provides a diagnosis of cancer.
Where is Adela headquartered?
Adela is headquartered in Foster City, US.
Which VCs invest in companies like Adela?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Adela's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Adela? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.